Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Gene Expression Data
100%
Cervical Cancer
100%
Metabolic Response
100%
Novel Therapeutic Targets
100%
Pathway-specific
100%
Specific Analysis
100%
Immunohistochemistry
50%
Gene Expression Profiling
50%
FDG Uptake
50%
Positive Groups
50%
Tumor Metabolism
50%
Gene Set Enrichment Analysis
50%
Pretreatment Biopsy
50%
Gene Expression
25%
Tissue Microarray
25%
Signaling Pathway
25%
Positron Emission Tomography
25%
Poor Prognosis
25%
Positron Emission Tomography-computed Tomography (PET-CT)
25%
Cervical Tumor
25%
Uptake Assay
25%
Tumor Response
25%
Chemoradiation
25%
Concurrent Chemotherapy
25%
Tissue Collection
25%
Fluorodeoxyglucose
25%
18F-fluoro-2-deoxy-D-glucose
25%
Survival Outcomes
25%
Affymetrix
25%
Gene chip
25%
AKT1
25%
Survival Estimation
25%
Cause-specific Survival
25%
Targeted Inhibition
25%
LY294002
25%
Phosphatidylinositol 3-kinase Inhibitor
25%
Definitive Radiation
25%
Invasive Cervical Cancer
25%
AKT Pathway
25%
Complete Metabolic Response
25%
Cervical Cancer Cell Line
25%
Fresh Frozen Tissue
25%
Medicine and Dentistry
Phosphoinositide 3-Kinase
100%
Gene Expression
100%
Cervical Cancer
100%
Metabolism
100%
Protein Kinase B
100%
Polyethylene Terephthalate
100%
Biopsy Technique
80%
Neoplasm
60%
Immunohistochemistry
40%
Gene Expression Profiling
40%
In Vitro
40%
Genome-Wide Analysis of Gene Expression
40%
Biological Marker
20%
Positron Emission Tomography-Computed Tomography
20%
Positron Emission Tomography
20%
Tissue Microarray
20%
Fluorodeoxyglucose F 18
20%
Uptake Assay
20%
Chemoradiotherapy
20%
Tissue Banking
20%
Cell Signaling Pathway
20%
Survival Estimate
20%
Cause Specific Survival
20%
Phosphoinositide 3-Kinase Inhibitor
20%
LY294002
20%
Pi3K/Akt Signaling
20%
Cervical Cancer Cell Line
20%